Cas 1039733-90-8,1,4-(((2-dimethylamino)-6-(3-vinylphenyl)quinazolin-4-ylamino)methyl)-N-(4-fluorophenyl)benzamide

1039733-90-8

Post Buying Request

Basic information

Product Name: 1,4-(((2-dimethylamino)-6-(3-vinylphenyl)quinazolin-4-ylamino)methyl)-N-(4-fluorophenyl)benzamide
Synonyms: 1,4-(((2-dimethylamino)-6-(3-vinylphenyl)quinazolin-4-ylamino)methyl)-N-(4-fluorophenyl)benzamide
CAS NO:1039733-90-8
Molecular Formula:
Molecular Weight: 441.508
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1,4-(((2-dimethylamino)-6-(3-vinylphenyl)quinazolin-4-ylamino)methyl)-N-(4-fluorophenyl)benzamide(CAS DataBase Reference)
NIST Chemistry Reference: 1,4-(((2-dimethylamino)-6-(3-vinylphenyl)quinazolin-4-ylamino)methyl)-N-(4-fluorophenyl)benzamide(1039733-90-8)
EPA Substance Registry System: 1,4-(((2-dimethylamino)-6-(3-vinylphenyl)quinazolin-4-ylamino)methyl)-N-(4-fluorophenyl)benzamide(1039733-90-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1039733-90-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1039733-90-8 Suppliers

Recommended suppliers

1039733-90-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1039733-90-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,9,7,3 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1039733-90:
(9*1)+(8*0)+(7*3)+(6*9)+(5*7)+(4*3)+(3*3)+(2*9)+(1*0)=158
158 % 10 = 8
So 1039733-90-8 is a valid CAS Registry Number.

1039733-90-8Upstream product

1039733-90-8Downstream Products

1039733-90-8Relevant academic research and scientific papers

AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS

-

Page/Page column 91, (2008/12/07)

The present invention relates to amino-substituted quinazoline derivatives as inhibitors of β-catenin/tcf-4 pathway, which can be useful in the treatment of cancer; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1039733-90-8